About one in three individuals with atherosclerotic cardiovascular disease (ASCVD) did not receive an influenza vaccination in the past year.
Baloxavir marboxil was well-tolerated in a pediatric population and rapidly reduced viral titers.
The FDA has approved a supplemental NDA for Xofluza for the treatment of acute, uncomplicated influenza in patients aged 12 years and older.
While oral oseltamivir decreased viral shedding in adults with influenza and without risk factors for complications of influenza compared with placebo, it did not significantly decrease the time to resolution of clinical symptoms.
The risk for hospitalization with pandemic influenza is higher for patients with type 2 diabetes than for those without type 2 diabetes.
Seasonal influenza viruses are circulating widely in the Southern Hemisphere, but influenza activity is currently low in the United States.
Many US adults, including some at the highest risk for the flu and pneumonia, do not plan to get preventive vaccines.
Early events in vaccine-induced immunity may be blunted in repeatedly vaccinated individuals.
The use of N95 respirators vs medical masks among outpatient healthcare personnel resulted in no differences in incidence of laboratory-confirmed influenza.
Probiotics could reduce the health care and economic burden of flu-like respiratory tract infections.
Compared with the standard-dose influenza vaccine, a high-dose quadrivalent inactivated influenza vaccine, GC3114, may provide a more effective influenza vaccine option for the elderly population.
The recommendations of the ACIP relating to the use of seasonal influenza vaccines in the United States have been updated for 2019 to 2020.
The use of corticosteroids in people with influenza pneumonia may increase rates of mortality.
There were no associations found between exposure to the 2009 pandemic H1N1 influenza vaccine during pregnancy and most 5-year pediatric outcomes.
Providing an educational handout about influenza disease in the waiting room before a pediatric provider visit may increase receipt of child influenza vaccine.
Workplace absenteeism during the high-severity 2017 to 2018 influenza season increased sharply in November and peaked in January.
According to results from the MINISTONE-2 trial, baloxavir marboxil (Xofluza) was found to be safe and effective in children 1 to less than 12 years old with an influenza infection.
Observations of 2 hygiene protocols undertaken by hospital staff found that the “Masks Save Lives” campaign is highly effective in preventing nosocomial influenza infection in clinical settings, according to data presented at American Society of Microbiology (ASM) Microbe 2019 held from June 20-24, 2019 in San Francisco, California. In 2018, the “Masks Save Lives” campaign…
Season was of moderate severity and lasted 21 weeks; illness mainly attributed to influenza A viruses
There were 125 reports of 192 patients receiving expired injectable inactivated influenza vaccines during the last flu season.